
Exploring Treatments and Challenges in Long COVID Research
As 2024 concludes, researchers have identified several promising treatments for long COVID, a condition affecting 17 million Americans. Low-dose naltrexone, SSRIs, modafinil, metformin, and antihistamines have shown potential in alleviating symptoms like brain fog, fatigue, and pain. However, the effectiveness of these treatments varies among patients, and large-scale clinical trials are still needed to determine their efficacy and safety. Physicians caution against indiscriminate use due to potential risks and interactions.
